Gregory Cary, Ph.D.

Bioinformatics Analyst III

Prioritizing candidate drug targets for diseases with complex etiologies

My research has focused on the logic of gene expression regulation, particularly in response to stress. In particular, I have utilized and integrated high-dimensional data to address complex questions about regeneration, neurodegeneration, development, and evolution. My role in the Open-AD consortium is to integrate genomic evidence in support of the prioritization and development of new therapeutic targets for the treatment of Alzheimer's disease.

Gregory Cary on ORCID



          Download CV         

Education and experience

Education

Carnegie Mellon University
Postdoctoral fellow
Adv: Dr. Veronica Hinman
2014-2020

University of Washington
Ph.D., Molecular and Cellular Biology
Adv: Aimee Dudley
2006-2013

Colby College
B.A., Biology
2000-2004